NIH-funded research NIH-funded research

Investigating ovarian health in women with sickle cell anemia

Official title: OVARIAN RESERVE IN POST-MENARCHAL FEMALES WITH SICKLE CELL ANEMIA

Funded at Johns Hopkins University · NIH-10901879 · Data updated 2026-11-12

This study is looking at how sickle cell anemia and its treatment with hydroxyurea might affect women's ability to have children, helping to provide important information for women with this condition about their reproductive health.

More Anemia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startAugust 9, 2020
Project endJuly 31, 2025
Funding year2024
Award (this year)$198,065
NIH project number5K23HL146841-05
Project IDNIH-10901879 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women diagnosed with sickle cell anemia, particularly those who have been treated with hydroxyurea.

Less likely to help

Patients without a diagnosis of sickle cell anemia or those who have not received treatment with hydroxyurea may not benefit from this research.

What this research studies

This research focuses on understanding how sickle cell anemia (SCA) and its treatment with hydroxyurea may impact ovarian reserve in women. By evaluating the reproductive health of women with SCA, the study aims to identify potential risks associated with fertility and the effects of long-term treatment. The research will involve a detailed assessment of ovarian function and how it relates to the severity of the disease and treatment duration. This information is crucial for guiding reproductive health decisions for women living with SCA.

Why it matters

Potential benefit: If successful, this research could provide critical insights that help improve fertility management and reproductive health care for women with sickle cell anemia.

How similar studies have gone: Previous research has indicated potential fertility risks associated with sickle cell anemia and its treatments, suggesting that this area of investigation is both relevant and necessary.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Pecker, Lydia — Johns Hopkins University
  • Study coordinator: Pecker, Lydia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.